The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Audeh, M. W., Carmichael, J., Penson, R. T., Friedlander, M., Powell, B., Bell-McGuinn, K. M., Scott, C., Weitzel, J. N., Oaknin, A., Loman, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60893-8 · Cited by 2,279
Tutt, A., Robson, M., Garber, J. E., Domchek, S. M., Audeh, M. W., Weitzel, J. N., Friedlander, M., Arun, B., Loman, N., Schmutzler, R. K., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60892-6 · Cited by 1,655
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Sakai, W., Swisher, E. M., Karlan, B. Y., Agarwal, M. K., Higgins, J., Friedman, C., Villegas, E., Jacquemont, C., Farrugia, D. J., Couch, F. J., et al. (2008) · Nature · doi:10.1038/nature06633 · Cited by 1,086
DNA interstrand crosslink repair and cancer
Deans, A. J., & West, S. C. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3088 · Cited by 1,023
Fong, P. C., Yap, T. A., Boss, D. S., Carden, C. P., Mergui-Roelvink, M., Gourley, C., De Greve, J., Lubinski, J., Shanley, S., Messiou, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.9589 · Cited by 1,010
Bouwman, P., Aly, A., Escandell, J. M., Pieterse, M., Bartkova, J., van der Gulden, H., Hiddingh, S., Thanasoula, M., Kulkarni, A., Yang, Q., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1831 · Cited by 1,001
Self-citationRottenberg, S., Jaspers, J. E., Kersbergen, A., van der Burg, E., Nygren, A. O. H., Zander, S. A. L., Derksen, P. W. B., de Bruin, M., Zevenhoven, J., Lau, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806092105 · Cited by 956
Self-citationLakhani, S. R., van de Vijver, M. J., Jacquemier, J., Anderson, T. J., Osin, P. P., McGuffog, L., & Easton, D. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.023 · Cited by 823
Platinum Resistance: The Role of DNA Repair Pathways
Martin, L. P., Hamilton, T. C., & Schilder, R. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2238 · Cited by 751
Hashizume, R., Fukuda, M., Maeda, I., Nishikawa, H., Oyake, D., Yabuki, Y., Ogata, H., & Ohta, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000881200 · Cited by 634
Friedman, L. S., Ostermeyer, E. A., Szabo, C. I., Dowd, P., Lynch, E. D., Rowell, S. E., & King, M.-C. (1994) · Nature Genetics · doi:10.1038/ng1294-399 · Cited by 622
Bhattacharyya, A., Ear, U. S., Koller, B. H., Weichselbaum, R. R., & Bishop, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000276200 · Cited by 583
BRCA1 and its toolbox for the maintenance of genome integrity
Huen, M. S. Y., Sy, S. M. H., & Chen, J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2831 · Cited by 490
BRCA1 tumour suppression occurs via heterochromatin-mediated silencing
Zhu, Q., Pao, G. M., Huynh, A. M., Suh, H., Tonnu, N., Nederlof, P. M., Gage, F. H., & Verma, I. M. (2011) · Nature · doi:10.1038/nature10371 · Cited by 485
Liu, X., Holstege, H., van der Gulden, H., Treur-Mulder, M., Zevenhoven, J., Velds, A., Kerkhoven, R. M., van Vliet, M. H., Wessels, L. F. A., Peterse, J. L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702969104 · Cited by 474
Self-citationS-phase–specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51
Taniguchi, T., Garcia-Higuera, I., Andreassen, P. R., Gregory, R. C., Grompe, M., & D'Andrea, A. D. (2002) · Blood · doi:10.1182/blood-2002-01-0278 · Cited by 461
Secondary BRCA1 Mutations in BRCA1 -Mutated Ovarian Carcinomas with Platinum Resistance
Swisher, E. M., Sakai, W., Karlan, B. Y., Wurz, K., Urban, N., & Taniguchi, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0088 · Cited by 457
Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer
Castilla, L. H., Couch, F. J., Erdos, M. R., Hoskins, K. F., Calzone, K., Garber, J. E., Boyd, J., Lubin, M. B., Deshano, M. L., Brody, L. C., et al. (1994) · Nature Genetics · doi:10.1038/ng1294-387 · Cited by 383
Moynahan, M. E., Cui, T. Y., & Jasin, M. (2001) · PubMed · Cited by 382
Xu, X., Qiao, W., Linke, S. P., Cao, L., Li, W.-M., Furth, P. A., Harris, C. C., & Deng, C.-X. (2001) · Nature Genetics · doi:10.1038/90108 · Cited by 373
Ruffner, H., Joazeiro, C. A. P., Hemmati, D., Hunter, T., & Verma, I. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081068398 · Cited by 359
Tirkkonen, M., Johannsson, O. T., Agnarsson, B. A., Olsson, H. L., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J. J., Barkardottir, R. B., Borg, Å., et al. (1997) · PubMed · Cited by 354
E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages
Christensen, D. E., Brzovic, P. S., & Klevit, R. E. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1295 · Cited by 351
Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex
Brzovic, P. S., Keeffe, J. R., Nishikawa, H., Miyamoto, K., Fox, D., Fukuda, M., Ohta, T., & Klevit, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0836054100 · Cited by 346
Graeser, M., McCarthy, A., Lord, C. J., Savage, K., Hills, M., Salter, J., Orr, N., Parton, M., Smith, I. E., Reis-Filho, J. S., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1027 · Cited by 327
Sakai, W., Swisher, E. M., Jacquemont, C., Chandramohan, K. V., Couch, F. J., Langdon, S. P., Wurz, K., Higgins, J., Villegas, E., & Taniguchi, T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1178 · Cited by 321
Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53 –Mediated Mouse Mammary Tumors
Shafee, N., Smith, C. R., Wei, S., Kim, Y., Mills, G. B., Hortobagyi, G. N., Stanbridge, E. J., & Lee, E. Y.-H. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5480 · Cited by 308
Rottenberg, S., Nygren, A. O. H., Pajic, M., van Leeuwen, F. W. B., van der Heijden, I., van de Wetering, K., Liu, X., de Visser, K. E., Gilhuijs, K. G., van Tellingen, O., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702955104 · Cited by 304
Self-citationTHE GENETICS OF BREAST CANCER SUSCEPTIBILITY
Rahman, N., & Stratton, M. R. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.95 · Cited by 295
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
Ishida, S., McCormick, F., Smith-McCune, K., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.011 · Cited by 288
Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains
Mallery, D. L. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf691 · Cited by 282
Morris, J. R., & Solomon, E. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh095 · Cited by 269
Self-citationMouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
Evers, B., & Jonkers, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209871 · Cited by 251
Self-citationBRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity
Shakya, R., Reid, L. J., Reczek, C. R., Cole, F., Egli, D., Lin, C.-S., deRooij, D. G., Hirsch, S., Ravi, K., Hicks, J. B., et al. (2011) · Science · doi:10.1126/science.1209909 · Cited by 244
Vollebergh, M. A., Lips, E. H., Nederlof, P. M., Wessels, L. F. A., Schmidt, M. K., van Beers, E. H., Cornelissen, S., Holtkamp, M., Froklage, F. E., de Vries, E. G. E., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq624 · Cited by 200
Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein
Xia, Y., Pao, G. M., Chen, H.-W., Verma, I. M., & Hunter, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204591200 · Cited by 196
Fabbro, M., Rodriguez, J. A., Baer, R., & Henderson, B. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200769200 · Cited by 187
Joukov, V., Chen, J., Fox, E. A., Green, J. B. A., & Livingston, D. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211427098 · Cited by 161
BRCA1 RING Domain Cancer-predisposing Mutations
Brzović, P. S., Meza, J. E., King, M., & Klevit, R. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106551200 · Cited by 135
Ransburgh, D. J. R., Chiba, N., Ishioka, C., Toland, A. E., & Parvin, J. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2850 · Cited by 131
BRCA1-independent ubiquitination of FANCD2
Vandenberg, C. J., Gergely, F., Ong, C. Y., Pace, P., Mallery, D. L., Hiom, K., & Patel, K. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00281-8 · Cited by 131
Reid, L. J., Shakya, R., Modi, A. P., Lokshin, M., Cheng, J., Jasin, M., Baer, R. J., & Ludwig, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811203106 · Cited by 131
Shakya, R., Szabolcs, M. J., McCarthy, E. E., Ospina, E., Basso, K., Nandula, S. V., Murty, V. V., Baer, R. J., & Ludwig, T. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711032105 · Cited by 125
Asakawa, H., Koizumi, H., Koike, A., Takahashi, M., Wu, W., Iwase, H., Fukuda, M., & Ohta, T. (2010) · Breast Cancer Research · doi:10.1186/bcr2486 · Cited by 98
Lips, E. H., Mulder, L., Hannemann, J., Laddach, N., Peeters, M.-J. T. F. D. V., van de Vijver, M. J., Wesseling, J., Nederlof, P. M., & Rodenhuis, S. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq468 · Cited by 84
Evers, B., Schut, E., van der Burg, E., Braumuller, T. M., Egan, D. A., Holstege, H. H., Edser, P. A. H., Adams, D. J., Wade‐Martins, R., Bouwman, P., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2434 · Cited by 78
Self-citationExpression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations
Chang, S., Biswas, K., Martin, B. K., Stauffer, S., & Sharan, S. K. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39836 · Cited by 76
Klijn, C. N., Holstege, H. H., de Ridder, J., Liu, X., Reinders, M. J. T., Jonkers, J., & Wessels, L. F. A. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1143 · Cited by 70
Self-citationHohenstein, P., Kielman, M. F., Breukel, C., Bennett, L. M., Wiseman, R. W., Krimpenfort, P., Cornelisse, C. J., van Ommen, G. B., Devilee, P., & Fodde, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204363 · Cited by 58
Preclinical mouse models for BRCA1-associated breast cancer
Drost, R., & Jonkers, J. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605350 · Cited by 48
Self-citationCross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers
Holstege, H. H., van Beers, E., Velds, A., Liu, X., Joosse, S. A., Klarenbeek, S., Schut, E., Kerkhoven, R. M., Klijn, C. N., Wessels, L. F. A., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-455 · Cited by 43
Self-citationNelson, A., & Holt, J. T. (2010) · Radiation Research · doi:10.1667/rr1290.1 · Cited by 40
Studying Drug Resistance Using Genetically Engineered Mouse Models for Breast Cancer
Rottenberg, S., Pajic, M., & Jonkers, J. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_3 · Cited by 12
Self-citation
Cited by
Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
Chapman, J. R., Taylor, M. R. G., & Boulton, S. J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.07.029 · Cited by 1,625
Accurate classification of BRCA1 variants with saturation genome editing
Findlay, G. M., Daza, R. M., Martin, B., Zhang, M. D., Leith, A. P., Gasperini, M., Janizek, J. D., Huang, X., Starita, L. M., & Shendure, J. (2018) · Nature · doi:10.1038/s41586-018-0461-z · Cited by 843
Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
Konstantinopoulos, P. A., Ceccaldi, R., Shapiro, G. I., & D'Andrea, A. D. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0714 · Cited by 945
Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
Prakash, R., Zhang, Y., Feng, W., & Jasin, M. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016600 · Cited by 869
The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance
Bouwman, P., & Jonkers, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3342 · Cited by 615
Self-citation
Metadata
- Authors
- Drost, R., Bouwman, P., Rottenberg, S., Boon, U., Schut, E., Klarenbeek, S., Klijn, C., van der Heijden, I., van der Gulden, H., Wientjens, E., Pieterse, M., Catteau, A., Green, P., Solomon, E., Morris, J. R., & Jonkers, J.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 20
- Issue
- 6
- Pages
- 797-809
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1989996784
- Cited by
- 262
- References
- 57
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.